September is Blood Cancer Awareness Month. It’s a month during which we will show you proof of the impact your support can have; an impact that reverberates through the entire field of cancer study.
According to the Leukemia and Lymphoma Society (LLS), blood cancer research is the leading edge of cancer research. It is helping us reach a new understanding about the genetic makeup of the disease and how to treat it.
Here’s some proof of impact:
• Therapies developed through LLS-funded research are now showing promise in other cancers, such as breast, lung, pancreatic, prostate and ovarian cancer.
• Nearly 40% of new cancer therapies approved by the FDA between 2000 and 2014 were first approved for blood cancer patients.
• LLS-funded researchers have helped advance targeted therapies for patients with chronic myeloid leukemia and other B-cell cancers, and have received FDA approval for these therapies in just the past two years.
These advances were only made possible because of your continued support. Help us keep the momentum going. Join us and help us prove that leading-edge research is conquering cancer and saving lives.
Donate today, and join the conversation at #LLSPROOF.